Hicin Pharmaceutical released its performance for the first three quarters, with a net profit attributable to the parent company of 32.6785 million yuan, a year-on-year increase of 16.22%
According to the Zhitong Finance APP, Hicin Pharmaceutical released its third-quarter report for 2025. In the first three quarters, the company achieved operating revenue of 472 million yuan, a year-on-year increase of 30.80%. The net profit attributable to shareholders of the listed company was 32.6785 million yuan, a year-on-year increase of 16.22%. The net profit attributable to shareholders of the listed company after deducting non-recurring gains and losses was 29.5431 million yuan, a year-on-year increase of 1.64%
According to the Zhitong Finance APP, Hicin Pharmaceutical (300584.SZ) released its third-quarter report for 2025. In the first three quarters, the company achieved an operating income of 472 million yuan, a year-on-year increase of 30.80%. The net profit attributable to shareholders of the listed company was 32.6785 million yuan, a year-on-year increase of 16.22%. The net profit attributable to shareholders of the listed company after deducting non-recurring gains and losses was 29.5431 million yuan, a year-on-year increase of 1.64%
